Epigenetic regulation of epithelial to mesenchymal transition by the Lysine specific demethylase LSD1/KDM1A

被引:46
|
作者
Ambrosio, Susanna [1 ]
Sacca, Carmen D. [1 ]
Majello, Barbara [1 ]
机构
[1] Univ Naples Federico II, Dept Biol, Naples, Italy
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS | 2017年 / 1860卷 / 09期
关键词
EMT; LSD1; Chromatin; Cell migration and invasion; Cancer; HISTONE DEMETHYLASE; TRANSCRIPTIONAL REPRESSION; LSD1; CANCER; METASTASIS; INHIBITION; PHOSPHORYLATION; COREST; GENES; EMT;
D O I
10.1016/j.bbagrm.2017.07.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Lysine-specific demethylase 1, KDM1A/LSD1, plays a central role in the regulation of Pol II transcription through the removal of the activation mark (mono- and dimethyl lysine 4 of histone H3). LSD1 is often deregulated in human cancers, and it is frequently overexpressed in human solid cancers and leukemia. LSD1 regulates the epithelial mesenchymal transition (EMT) in epithelial cells, i.e., the ability to transition into mesenchymal cells, to lose homotypic adhesion and to acquire migratory capacity. From its initial discovery as a component of the Snail complex, multiple studies highlighted the causative role of LSD1 in cell invasiveness and EMT, describing its direct involvement in different molecular processes through the interaction with specific partners. Here we present an overview of the role of LSD1 in the EMT process, summarizing recent findings on its emerging functions in cell migration and invasion in cancer.
引用
收藏
页码:905 / 910
页数:6
相关论文
共 50 条
  • [21] Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase1(LSD1/KDM1A)
    Zhonghua Li
    Lina Ding
    Zhongrui Li
    Zhizheng Wang
    Fengzhi Suo
    Dandan Shen
    Taoqian Zhao
    Xudong Sun
    Junwei Wang
    Ying Liu
    Liying Ma
    Bing Zhao
    Pengfei Geng
    Bin Yu
    Yichao Zheng
    Hongmin Liu
    Acta Pharmaceutica Sinica B, 2019, 9 (04) : 794 - 808
  • [22] Capsaicin: A "hot" KDM1A/LSD1 inhibitor from peppers
    Jia, Gang
    Cang, Shundong
    Ma, Peizhi
    Song, Zhiyu
    BIOORGANIC CHEMISTRY, 2020, 103
  • [23] Annual review of LSD1/KDM1A inhibitors in 2020
    Fu, Dong-Jun
    Li, Jun
    Yu, Bin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 214
  • [24] Lysine-specific histone demethylase LSD1 and the dynamic control of chromatin
    Rudolph, Thomas
    Beuch, Stefanie
    Reuter, Gunter
    BIOLOGICAL CHEMISTRY, 2013, 394 (08) : 1019 - 1028
  • [25] Regulation of Lipogenic Gene Expression by Lysine-specific Histone Demethylase-1 (LSD1)
    Abdulla, Arian
    Zhang, Yi
    Hsu, Fu-Ning
    Xiaoli, Alus M.
    Zhao, Xiaoping
    Yang, Ellen S. T.
    Ji, Jun-Yuan
    Yang, Fajun
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (43) : 29937 - 29947
  • [26] KDM1A/LSD1 regulates the differentiation and maintenance of spermatogonia in mice
    Myrick, Dexter A.
    Christopher, Michael A.
    Scott, Alyssa M.
    Simon, Ashley K.
    Donlin-Asp, Paul G.
    Kelly, William G.
    Katz, David J.
    PLOS ONE, 2017, 12 (05):
  • [27] The Role of Lysine-Specific Demethylase 1 (LSD1) in Shaping the Endothelial Inflammatory Response
    Wojtala, Martyna
    Rybaczek, Dorota
    Wielgus, Ewelina
    Sobalska-Kwapis, Marta
    Strapagiel, Dominik
    Balcerczyk, Aneta
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (05) : 569 - 589
  • [28] Novel spirocyclic tranylcypromine derivatives as lysine-specific demethylase 1 (LSD1) inhibitors
    Shi, Ying
    Wu, Yan-Ran
    Su, Ming-Bo
    Shen, Dong-Hao
    Gunosewoyo, Hendra
    Yang, Fan
    Li, Jia
    Tang, Jie
    Zhou, Yu-Bo
    Yu, Li-Fang
    RSC ADVANCES, 2018, 8 (03): : 1666 - 1676
  • [29] Recent advances of LSD1/KDM1A inhibitors for disease therapy
    Zhang, Chaofeng
    Wang, Zhiyuan
    Shi, Yuting
    Yu, Bin
    Song, Yihui
    BIOORGANIC CHEMISTRY, 2023, 134
  • [30] LSD1/KDM1A inhibitors in clinical trials: advances and prospects
    Yuan Fang
    Guochao Liao
    Bin Yu
    Journal of Hematology & Oncology, 12